Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Glaucoma: diagnosis and management

NICE guideline
Reference number: NG81
Published: 01 November 2017
Last updated: 26 January 2022

History

Consultation comments published

Consultation comments and responses (PDF 661 KB)

Published:

26 January 2022

Equality and health inequalities assessment

Equality impact assessment (PDF 308 KB)

Published:

26 January 2022

Draft guidance consultation

Draft guidance consultation
Comments form (MSWord 38 KB)

Published:

25 November 2021
Committee member list (PDF 117 KB)

Published:

25 November 2021
Draft guideline (PDF 709 KB)

Published:

25 November 2021
Committee member list DOI (PDF 190 KB)

Published:

25 November 2021
Evidence review (PDF 2.46 MB)

Published:

25 November 2021
Equality impact assessment (PDF 337 KB)

Published:

25 November 2021

Pre-consultation documents released

Review questions (PDF 146 KB)

Published:

26 October 2021
Search strategies (PDF 351 KB)

Published:

08 November 2021

Committee meetings

Committee meeting
Minutes 1 (PDF 182 KB)

Published:

11 October 2021

Declaration of interests

Register of interests (PDF 190 KB)

Published:

26 January 2022

Committee list updated

Committee member list (PDF 117 KB)

Published:

26 January 2022

Stakeholder list updated

Stakeholder list (PDF 131 KB)

Published:

23 August 2021

Scope published

Final scope (PDF 195 KB)

Published:

23 August 2021
Equality impact assessment 1 (PDF 162 KB)

Published:

13 September 2021

Original development on 01 November 2017

Guidance published
Committee member list (PDF 421 KB)

Published:

01 November 2017
Equality impact assessment 4 (PDF 219 KB)

Published:

01 November 2017
Guidance consultation comments and response (PDF 999 KB)

Published:

01 November 2017
Stakeholder list updated
Stakeholder list (PDF 151 KB)

Published:

16 August 2017
Draft guidance consultation
Draft guidance consultation
Stakeholder list (Excel 21 KB)

Published:

06 June 2017
Equality impact assessment 3 (PDF 266 KB)

Published:

06 June 2017
Comments form Large font (MSWord 63 KB)

Published:

06 June 2017
Comments form (MSWord 62 KB)

Published:

06 June 2017
Short version of draft guideline (PDF 619 KB)

Published:

06 June 2017
Draft guideline (PDF 4.04 MB)

Published:

06 June 2017
Guideline appendices A-T (PDF 8.92 MB)

Published:

06 June 2017
Guideline appendix U (PDF 8.1 MB)

Published:

06 June 2017
Short version of draft guideline LARGE FONT (PDF 629 KB)

Published:

06 June 2017
Pre-consultation documents released
Review questions (PDF 188 KB)

Published:

27 April 2017
Economic plan (PDF 130 KB)

Published:

27 April 2017
Search strategies (PDF 1.04 MB)

Published:

27 April 2017
Equality and health inequalities assessment
Equality impact assessment 1 (PDF 118 KB)

Published:

11 August 2016
Equality impact assessment 2 (PDF 212 KB)

Published:

11 August 2016
Scope published
Final scope (PDF 212 KB)

Published:

21 July 2016
Consultation comments published
Consultation comments and responses (PDF 281 KB)

Published:

21 July 2016
Draft scope consultation
Draft scope consultation
Draft scope (PDF 217 KB)

Published:

19 May 2016
Comments form (MSWord 63 KB)

Published:

19 May 2016
Committee meeting
Minutes 1 (PDF 105 KB)

Published:

26 July 2016
Minutes 2 (PDF 105 KB)

Published:

21 September 2016
Minutes 3 (PDF 107 KB)

Published:

25 October 2016
Minutes 4 (PDF 110 KB)

Published:

29 November 2016
Minutes 5 (PDF 183 KB)

Published:

16 January 2017
Minutes 6 (PDF 107 KB)

Published:

28 February 2017
Minutes 7 (PDF 107 KB)

Published:

01 March 2017
Minutes 8 (PDF 206 KB)

Published:

28 March 2017
Minutes 9 (PDF 202 KB)

Published:

29 March 2017
Minutes 10 (PDF 88 KB)

Published:

18 July 2017